Kevin J Martin
Overview
Explore the profile of Kevin J Martin including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
68
Citations
1753
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Karaboyas A, Zhao J, Ma J, Moore C, Saleem N, Martin K, et al.
Clin J Am Soc Nephrol
. 2024 Oct;
PMID: 39378354
No abstract available.
2.
Kalantar-Zadeh K, Forfang D, Bakris G, Martin K, Moe S, Sprague S
Kidney360
. 2023 Oct;
4(11):1650-1656.
PMID: 37870525
Most patients receiving dialysis rely on dietary restriction and phosphate binders to minimize the risk of hyperphosphatemia, which is associated with increased mortality. However, dietary restriction is difficult because of...
3.
Bellorin-Font E, Rojas E, Martin K
Nutrients
. 2023 Jan;
15(1).
PMID: 36615824
Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD) comprises alterations in calcium, phosphorus, parathyroid hormone (PTH), Vitamin D, and fibroblast growth factor-23 (FGF-23) metabolism, abnormalities in bone turnover, mineralization, volume, linear...
4.
Vasquez-Rios G, Chapel A, Philip I, Martin K, Merando A
Nefrologia (Engl Ed)
. 2022 Sep;
41(4):467-470.
PMID: 36165116
No abstract available.
5.
Zuo X, Venkitasubramanian P, Martin K, Subramaniam B
ChemSusChem
. 2021 Dec;
15(13):e202102050.
PMID: 34913609
The oxidation of 5-hydroxymethylfurfural (HMF) produces value-added chemicals such as 2,5-diformylfuran (DFF) and 2,5-furandicarboxylic acid (FDCA). In this work, FDCA production was achieved by oxidation of crude HMF solution containing...
6.
Goodman W, Ward D, Martin K, Drayer D, Moore C, Xu J, et al.
J Am Soc Nephrol
. 2021 Nov;
33(1):201-212.
PMID: 34732508
Background: Phosphorus levels in the range seen clinically among patients undergoing dialysis have been reported to attenuate calcium receptor activation and modify parathyroid hormone (PTH) release from isolated parathyroid glands...
7.
Sprague S, Martin K, Coyne D
Kidney Int Rep
. 2021 Aug;
6(8):2049-2058.
PMID: 34386654
Chronic kidney disease-mineral bone disorder (CKD-MBD) is a common comorbidity in patients with CKD. Characterized by laboratory abnormalities, bone abnormality, and vascular calcification, CKD-MBD encompasses a group of mineral and...
8.
Martin K
Nephrol Dial Transplant
. 2021 Jul;
37(10):1830-1832.
PMID: 34320212
No abstract available.
9.
Bellorin-Font E, Vasquez-Rios G, Martin K
Curr Osteoporos Rep
. 2019 Sep;
17(5):333-342.
PMID: 31485996
Secondary hyperparathyroidism is a frequent complication of chronic kidney disease that begins early in the course of renal insufficiency as an adaptive response to maintain mineral homeostasis. This complex disorder...
10.
Bushinsky D, Chertow G, Cheng S, Deng H, Kopyt N, Martin K, et al.
Nephrol Dial Transplant
. 2019 May;
:1642.
PMID: 31093680
No abstract available.